Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.
Sieber M, Tesch H, Pfistner B, Rueffer U, Paulus U, Munker R, Hermann R, Doelken G, Koch P, Oertel J, Roller S, Worst P, Bischof H, Glunz A, Greil R, von Kalle K, Schalk KP, Hasenclever D, Brosteanu O, Duehmke E, Georgii A, Engert A, Loeffler M, Diehl V, Mueller RP, Willich N, Fischer R, Hansmann ML, Stein H, Schober T, Koch B; German Hodgkin's Lymphoma Study Group. Sieber M, et al. Among authors: oertel j. Ann Oncol. 2004 Feb;15(2):276-82. doi: 10.1093/annonc/mdh046. Ann Oncol. 2004. PMID: 14760122 Free article. Clinical Trial.
Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination of gemcitabine and bleomycin: a report of the German Hodgkin's Lymphoma Study Group.
Bredenfeld H, Franklin J, Nogova L, Josting A, Fries S, Mailänder V, Oertel J, Diehl V, Engert A; German Hodgkin's Lymphoma Study Group. Bredenfeld H, et al. Among authors: oertel j. J Clin Oncol. 2004 Jun 15;22(12):2424-9. doi: 10.1200/JCO.2004.09.114. Epub 2004 May 10. J Clin Oncol. 2004. PMID: 15136597 Clinical Trial.
Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG).
Nogová L, Reineke T, Eich HT, Josting A, Müller-Hermelink HK, Wingbermühle K, Brillant C, Gossmann A, Oertel J, Bollen MV, Müller RP, Diehl V, Engert A. Nogová L, et al. Among authors: oertel j. Ann Oncol. 2005 Oct;16(10):1683-7. doi: 10.1093/annonc/mdi323. Epub 2005 Aug 10. Ann Oncol. 2005. PMID: 16093276 Free article.
Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this Distinction.
Engelhard M, Brittinger G, Heinz R, Theml H, Bartels H, Binder T, Fülle HH, Gerhartz H, Gunzer U, Ludwig F, Ludwig WD, Nowicki L, Oertel J, Pees HW, Pralle H, Rühl U, Schilling CV, Spann W, Szeimies U, Wetzel HJ, Zwingers T, Feller AC, Stein H, Lennert K. Engelhard M, et al. Among authors: oertel j. Leuk Lymphoma. 1991;5 Suppl 1:161-73. doi: 10.3109/10428199109103400. Leuk Lymphoma. 1991. PMID: 27463501
CD 34 immunotyping of blasts in myelodysplasia.
Oertel J, Oertel B, Beyer J, Huhn D. Oertel J, et al. Among authors: oertel b. Ann Hematol. 1994 Feb;68(2):77-80. doi: 10.1007/BF01715135. Ann Hematol. 1994. PMID: 7511934
Immunotyping of blasts in human bone marrow.
Oertel J, Oertel B, Schleicher J, Huhn D. Oertel J, et al. Among authors: oertel b. Ann Hematol. 1996 Mar;72(3):125-9. doi: 10.1007/s002770050149. Ann Hematol. 1996. PMID: 8766253
372 results